Latest Articles

Publication Date
All News Scientific
EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis - BioSpace

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis BioSpace

Published: March 23, 2026, 12:47 p.m.
Read Full Article
EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis - PR Newswire

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis PR Newswire

Published: March 23, 2026, 11:30 a.m.
Read Full Article
Sur180 Therapeutics and Nura Health Announce Strategic Partnership to Advance Precision Diagnostics and Next-Generation Non-Hormonal Treatments for Endometriosis - Digital Journal

Sur180 Therapeutics and Nura Health Announce Strategic Partnership to Advance Precision Diagnostics and Next-Generation Non-Hormonal Treatments for Endometriosis Digital Journal

Published: March 18, 2026, 12:41 p.m.
Read Full Article
Sur180 Therapeutics and Nura Health Announce Strategic Partnership to Advance Precision Diagnostics and Next-Generation Non-Hormonal Treatments for Endometriosis - ACCESS Newswire

Sur180 Therapeutics and Nura Health Announce Strategic Partnership to Advance Precision Diagnostics and Next-Generation Non-Hormonal Treatments for Endometriosis ACCESS Newswire

Published: March 18, 2026, 10:13 a.m.
Read Full Article
FinancialContent - Sur180 Therapeutics and Nura Health Announce Strategic Partnership to Advance Precision Diagnostics and Next-Generation Non-Hormonal Treatments for Endometriosis - FinancialContent

FinancialContent - Sur180 Therapeutics and Nura Health Announce Strategic Partnership to Advance Precision Diagnostics and Next-Generation Non-Hormonal Treatments for Endometriosis FinancialContent

Published: March 18, 2026, 10 a.m.
Read Full Article
FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider

FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment Femtech Insider

Published: Feb. 18, 2026, 3:18 p.m.
Read Full Article
Hope Medicine Completes Phase 2 Trial of Non-Hormonal Endometriosis Treatment - Femtech Insider

Hope Medicine Completes Phase 2 Trial of Non-Hormonal Endometriosis Treatment Femtech Insider

Published: Oct. 8, 2025, 7:30 p.m.
Read Full Article
Swedish Biotech Gesynta Advances Non-Hormonal Endometriosis Treatment - insights.citeline.com

Swedish Biotech Gesynta Advances Non-Hormonal Endometriosis Treatment insights.citeline.com

Published: Sept. 25, 2025, 7:42 a.m.
Read Full Article
Sur180 gets nearly $2.4M NIH grant to develop non-hormonal endo treatment - News is My Business

Sur180 gets nearly $2.4M NIH grant to develop non-hormonal endo treatment News is My Business

Published: July 9, 2025, 9:03 a.m.
Read Full Article
Organon's non-hormonal endometriosis hope dashed - FirstWord Pharma

Organon's non-hormonal endometriosis hope dashed FirstWord Pharma

Published: July 2, 2025, 3:25 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!